ISSN: 0302-2838

Journal Home

Journal Guideline

European Urology Q1 Unclaimed

Elsevier B.V. Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

European Urology is a journal indexed in SJR in Urology with an H index of 261. It has an SJR impact factor of 6,928 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 6,928.

European Urology focuses its scope in these topics and keywords: cancer, prostate, patients, urol, eur, treatment, systematic, surveillance, response, review, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Urology (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

6,928

SJR Impact factor

261

H Index

338

Total Docs (Last Year)

1278

Total Docs (3 years)

5482

Total Refs

8525

Total Cites (3 years)

390

Citable Docs (3 years)

7.35

Cites/Doc (2 years)

16.22

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

The Lancet Neurology Q1
Neuro-Oncology Q1
Nature Reviews Neurology Q1
JAMA Neurology Q1
Molecular Neurodegeneration Q1

Compare this journals

Aims and Scope

Best articles by citations

Clinical Correlation of Prostatic Lithiasis with Chronic Pelvic Pain Syndromes in Young Adults

Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302

Investigating Genomic Aberrations of the Androgen Receptor: Moving Closer to More Precise Prostate Cancer Care?

Possible Causes of Unsuccessful Endoscopic Collagen Treatment of Vesicoureteric Reflux in Children

Stress Incontinence Injection Therapy: What is Best for Our Patients?

Prostate Cancer Detection is Also Relevant in Low Prostate Specific Antigen Ranges

Interleukin-2, Interferon-a and 5-Fluorouracil Immunotherapy for Metastatic Renal Cell Carcinoma: The All Ireland Experience

T1G3 Bladder Cancer: Conservative Management or Cystectomy?

Hyperbaric Oxygen for the Treatment of Interstitial Cystitis: Long-Term Results of a Prospective Pilot Study

Reply to J. Bharadwa and V.H. Nargund

Laparoscopic Surgery for Pheochromocytoma

Chromosomal High-Polysomies Predict Tumour Progression in T1 Transitional Cell Carcinoma of the Bladder

SHOW MORE ARTICLES

Evaluation of the Clinical Benefit of Permixon and Tamsulosin in Severe BPH Patients - PERMAL Study Subset Analysis

Engineered FGF-2 Expression Induces Glandular Epithelial Hyperplasia in the Murine Prostatic Dorsal Lobe

Surgical Treatment of Female Stress Urinary Incontinence with a Trans-Obturator-Tape (T.O.T.¬Æ) Uratape¬Æ: Short Term Results of a Prospective Multicentric Study

The Role of Alpha-Blockers in the Management of Acute Urinary Retention Caused by Benign Prostatic Obstruction

Perioperative Blood Transfusion and Radical Cystectomy: Does Timing of Transfusion Affect Bladder Cancer Mortality?

TUR and Adjuvant Intravesical Chemotherapy in T1G3 Bladder Tumors: Recurrence, Progression and Survival in 137 Selected Patients Followed Up to 20 Years

Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review

Stress Proteins and Cytokines are Urinary Biomarkers for Diagnosis and Staging of Bladder Cancer

FSH in testis cancer

Celecoxib has Potent Antitumour Effects as a Single Agent and in Combination with BCG Immunotherapy in a Model of Urothelial Cell Carcinoma

The Effect of Nitric Oxide on the Resting Tone and the Contractile Behaviour of the External Urethral Sphincter: A Functional Urodynamic Study in Healthy Humans

Intraoperative Continuous Norepinephrine Infusion Combined with Restrictive Deferred Hydration Significantly Reduces the Need for Blood Transfusion in Patients Undergoing Open Radical Cystectomy: Results of a Prospective Randomised Trial